Company Financials

Kaken Pharmaceutical Co. Ltd Financials

Japanese yen

business Kaken Pharmaceutical Co. Ltd Company Profile

Main Stock Listing

JPX: 4521

Market Capitalization ¥146.55 Billion as of Jan. 1, 2026

Market Cap History

Valuations Metrics as of Jan. 3, 2026

Trailing PE 277.85
Forward PE 41.65
Price to Sales TTM ¥1.85
Price to Book MRQ ¥1.03
Enterprise to Revenue 1.20
Enterprise to EBITDA 22.56

Financial Reports as of Jun. 30, 2025

Financials

Fiscal Year Ends 2025-03-31
Most Recent Quarter 2025-06-30
Profit Margin 0.79%
Operating Margin 0.91%
Return on Assets TTM 0.57%
Return on Equity TTM 0.43%

Income Statement

Revenue TTM ¥82,019,000,320
Revenue per Share TTM ¥2146.90
Quarterly Revenue Growth -38.10%
Gross Profit TTM ¥46,009,999,360
EBITDA ¥23,893,000,000
Net Income to Common TTM ¥651,000,000
Diluted EPS TTM ¥14.45
Quarterly Earnings Growth YoY -94.20%

Balance Sheet

Total Cash MRQ ¥57,103,998,976
Total Cash per Share MRQ ¥1507.96
Total Debt MRQ ¥
Total Debt to Equity MRQ 2.61
Current Ratio MRQ 4.40
Book Value per Share MRQ ¥3903.03

Cash Flow

Operating Cash Flow TTM ¥-2,216,000,000
Levered Free Cash Flow TTM ¥-4,054,249,984

4521 Stock Info as of Jan. 3, 2026

Stock Statistics

Shares Outstanding 37,868,488
Float Shares 32,675,961
Avg 10 Volume 156,600
Avg 30 Volume None
Shares Short None
Short Ratio
Short % of Shares %
% Held by Insiders 17.25%
% Held by Institutions 23.16%

Stock Price Summary

Beta 0.07
Fifty Two Week Low ¥3540.00
Fifty Two Week High ¥4901.00
Fifty Two Week Change -14.00%
Day 50 MA ¥3825.30
Day 200 MA ¥3904.21

Dividends and Splits

Forward Annual Dividend Rate ¥190.00
Forward Annual Dividend Yield 4.73%
Trailing Annual Dividend Rate ¥170.00
Trailing Annual Dividend Yield 4.23%
Payout Ratio 1184.67%
Dividend Date
Ex Dividend Date 2026-03-30
Last Split Factor
Last Split Date 2015-09-28